FdaApplication
ANDA 205923
Identifiers
- fda_app_no: ANDA205923
Properties
| Property | Value |
|---|---|
| applicant_name | XELLIA PHARMACEUTICALS APS |
| application_type | ANDA |
| approval_date | 2018-07-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER;INTRAVENOUS |
| CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER;INTRAVENOUS |
2 products